Catheter Ablation of Atrial Fibrillation: Advances and Challenges

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: closed (15 July 2024) | Viewed by 707

Special Issue Editors


E-Mail Website
Guest Editor
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
Interests: atrial fibrillation; catheter ablation; arrhythmias; cardiac electrophysiology; heart failure; ventricular tachycardia; ventricular fibrillation; sudden cardiac death; cardiac devices

E-Mail Website
Guest Editor
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
Interests: atrial fibrillation; atrial flutter; atrial tachycardia; arrhythmias; sudden cardiac death; cardiac device; interventional cardiology

Special Issue Information

Dear Colleagues,

Atrial fibrillation (AF) is the most common heart rhythm disorder in the United States and many other countries across the globe. Numerous groundbreaking technologies and techniques in AF catheter ablation have been developed over the years, allowing it to mature as a durable option for rhythm control. Despite these advances, many gaps regarding the pathophysiology and mechanisms that initiate and sustain AF remain; in turn, these continue to underpin challenges that we encounter in terms of improving outcomes and minimizing complications.

In this Special Issue, we summarize the tremendous progress made in terms of AF catheter ablation and provide a preview of emerging therapies/modalities that are on the horizon. In addition, we highlight the challenges we currently face and opportunities for future growth. Researchers in the field of clinical arrhythmology and electrophysiology are encouraged to submit their findings as original articles or reviews to this Special Issue. Submissions focusing on innovative approaches, novel technologies, and outcomes of clinical studies are particularly encouraged.

Dr. Nicholas Yick Loong Tan
Dr. Christopher V. DeSimone
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atrial fibrillation
  • catheter ablation
  • pulmonary vein isolation
  • cardiac electrophysiology
  • cardiac resynchronization therapy
  • pulsed field ablation
  • hybrid ablation
  • non-pulmonary vein triggers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 264 KiB  
Review
Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure: Focus on the Latest Clinical Evidence
by Andrea Demarchi, Matteo Casula, Ginevra Annoni, Marco Foti and Roberto Rordorf
J. Clin. Med. 2024, 13(17), 5138; https://doi.org/10.3390/jcm13175138 - 29 Aug 2024
Viewed by 454
Abstract
Atrial fibrillation and heart failure are two common cardiovascular conditions that frequently coexist, and it has been widely demonstrated that in patients with chronic heart failure, atrial fibrillation is associated with a significant increase in the risk of all-cause death and all-cause hospitalization. [...] Read more.
Atrial fibrillation and heart failure are two common cardiovascular conditions that frequently coexist, and it has been widely demonstrated that in patients with chronic heart failure, atrial fibrillation is associated with a significant increase in the risk of all-cause death and all-cause hospitalization. Nevertheless, there is no unanimous consensus in the literature on how to approach this category of patients and which therapeutic strategy (rhythm control or frequency control) is the most favorable in terms of prognosis; moreover, there is still a lack of data comparing the different ablative techniques of atrial fibrillation in terms of efficacy, and many of the current trials do not consider current ablative techniques such as high-power short-duration ablation index protocol for radiofrequency pulmonary vein isolation. Eventually, while several RCTs have widely proved that in patients with heart failure with reduced ejection fraction, ablation of atrial fibrillation is superior to medical therapy alone, there is no consensus regarding those with preserved ejection fraction. For these reasons, in this review, we aim to summarize the main updated evidence guiding clinical decision in this complex scenario, with a special focus on the most recent trials and the latest meta-analyses that examined the role of catheter ablation (CA) in rhythm control in patients with AF and HF. Full article
(This article belongs to the Special Issue Catheter Ablation of Atrial Fibrillation: Advances and Challenges)
Back to TopTop